Company intelligence / Profile preview

Medspray

Enschede, Overijssel, Netherlandsmedspray.com ↗
Ownership
Private
Employees
~40
Development stage
Other
01

Overview

Medspray has developed a proprietary micro-nozzle “soft mist” spray technology that enables highly efficient and gentle pulmonary or nasal drug delivery. Their platform allows improved lung deposition with less degradation of sensitive biologicals compared to traditional nebulizers. The company partners with pharma/biotech firms to enable new inhaled/nasal products—including fragile modalities like mRNA vaccines—and has licensed its tech to companies such as Silo Pharma (for intranasal PTSD therapy) and Resyca/Recipharm for advanced combination products[2][5][6].

Modalities
DeviceInhaler-based drug delivery systemsNasal spray devices
Industry
Therapeutic Medical Devices
02

Partnerships

Silo Pharma (exclusive license for soft mist nasal spray in CNS indications including PTSD)[5]Recipharm/Resyca (exclusive license/collaboration for soft mist nasal/nasal+oral combination products)[6][7]Awarded Eurostars grant with Amferia to develop antimicrobial wound care sprays[1]

Beyond the preview

Go deeper on Medspray.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medspray.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call